Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tris DBA palladium (Tris DBA)
i
Other names:
Tris DBA
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Emory University School of Medicine
Drug class:
NLRP3 inhibitor, ARF6 inhibitor, GNAQ inhibitor, NMT-1 inhibitor
Related drugs:
‹
RRx-001 (2)
Bay11-7082 (0)
OLT1177 (0)
NAV-2729 (0)
DYP688 (0)
RRx-001 (2)
Bay11-7082 (0)
OLT1177 (0)
NAV-2729 (0)
DYP688 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
GNAQ mutation
Uveal Melanoma
GNAQ mutation
Uveal Melanoma
Tris DBA
Sensitive: D – Preclinical
Tris DBA
Sensitive
:
D
Tris DBA
Sensitive: D – Preclinical
Tris DBA
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login